Search research articles
Contact Us
Filters
Showing results (51-60 of 111) with videos related to
Page
of 12
Sort By:
Cancer Research
|
February 18, 2017
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues
Christina D Drenberg, Alice A Gibson, Stanley B Pounds, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Investigational New Drugs
|
May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML
Jae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
BMC Genomics
|
November 9, 2012
Methods for high-throughput MethylCap-Seq data analysis
Benjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
Cancer Chemotherapy and Pharmacology
|
August 29, 2014
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)
Jan H Beumer, Kouros Owzar, Lionel D Lewis, et al.
Leukemia & Lymphoma
|
September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study
Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Bone Marrow Transplantation
|
February 16, 2018
Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients
Daniel R Richardson, Ying Huang, Heather L McGinty, et al.
Haematologica
|
May 13, 2010
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
William Blum, Mitch A Phelps, Rebecca B Klisovic, et al.
Haematologica
|
May 19, 2018
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34<sup>+</sup>CD123<sup>+</sup> cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors
Rajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 111) with videos related to
Sort By:
Page
of 12
Cancer Research
|
February 18, 2017
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues
Christina D Drenberg, Alice A Gibson, Stanley B Pounds, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Investigational New Drugs
|
May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML
Jae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
BMC Genomics
|
November 9, 2012
Methods for high-throughput MethylCap-Seq data analysis
Benjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
Cancer Chemotherapy and Pharmacology
|
August 29, 2014
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)
Jan H Beumer, Kouros Owzar, Lionel D Lewis, et al.
Leukemia & Lymphoma
|
September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study
Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Bone Marrow Transplantation
|
February 16, 2018
Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients
Daniel R Richardson, Ying Huang, Heather L McGinty, et al.
Haematologica
|
May 13, 2010
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
William Blum, Mitch A Phelps, Rebecca B Klisovic, et al.
Haematologica
|
May 19, 2018
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34<sup>+</sup>CD123<sup>+</sup> cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors
Rajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, et al.
Page
of 12